APFM Section 2 Module 5: Special Considerations and Hot Topics

Module Description

 

 

Target Audience

Pharmacists, Pharmacy Technicians, Managed Care Professionals

Learning Objectives

At the completion of this activity, participants should be able to:

  • Define different FDA accelerated approval pathways and their implications on formulary management.
  • Discuss considerations for incorporating biosimilars, digital therapeutics, and high-investment therapies into a formulary.
  • Recognize health disparities and their influence on healthcare access and affordability.
  • Identify methods for collecting and integrating patient feedback into formulary management practices.
  • Summarize value-based care models and its impact on outcomes-based reimbursement and population health management.

 

Course summary
Course opens: 
01/01/2025
Course expires: 
06/30/2026
Cost:
$0.00

Faculty:

Spenser Smith, PharmD
Senior Clinical Pharmacist
Blue Cross Blue Shield of North Carolina

Financial Relationship Disclosures:

Faculty/Reviewer/PlannerReported Relevant Financial Relationships
Spenser Smith, PharmD
Faculty
None
  • AMCP Staff have disclosed no relevant financial relationships.
  • If applicable, relevant financial relationships have been mitigated and documented.
  • Content has undergone a peer review to ensure content validity.

Accreditation:

ACPE UAN:0233-0000-23-026-H04-P • Activity Type: Knowledge-Based
Contact Hours: 0.75
Release Date: August 04, 2023 •  Expiration Date: July 31, 2026

CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.

To receive credit for an online activity you must:

  • Review the full content of the activity.
  • Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
  • Complete a specific activity evaluation.

Price

Cost:
$0.00
Please login or register to take this course.